Abstract
An extensive neurochemical study has been performed on the CNS of Rolling mouse Nagoya (RMN), an ataxic mutant mouse. Although the symptoms observed are as severe as those found in Weaver mutants, little is known of the pathogenesis of the ataxia, except for a slight hypoplasia of the anterior part of the cerebellum. The present study revealed two major neurotransmitter-related abnormalities in the CNS. The first is a reduced concentration of glutamate, a putative transmitter of granule cells, and an increased concentration of glycine and taurine in the cerebellum of the RMN. The second is an increased activity of tyrosine hydroxylase, the rate-limiting enzyme in catecholamine synthesis, not only in the cerebellum but also in spinal cord, medulla oblongata, thalamus and hypothalamus. These results, together with previous data obtained from other ataxic mutant mice or experimentally-induced ataxic animals suggest that the cerebellum is the most severely affected part of the CNS in the RMN with the number of granule cells being reduced. The increase in the concentration of inhibitory amino acids and the widespread increase in tyrosine hydroxylase activity are probably not specific to the RMN but seem to be common to other ataxic ...Continue Reading
References
Apr 9, 1976·Brain Research·I B Black
Mar 18, 1977·Brain Research·P M Beart, V Lee
May 1, 1979·Journal of Neurochemistry·B H RohdeW J McBride
Feb 24, 1978·Brain Research·S Roffler-Tarlov, R L Sidman
Dec 11, 1978·Life Sciences·M A Rea, W J McBride
Nov 26, 1976·Brain Research·I Kanazawa, T Jessell
Feb 1, 1975·Journal of Neurochemistry·F Fonnum
Aug 8, 1975·Brain Research·S C LandisF E Bloom
May 1, 1976·Journal of Neurochemistry·W J McBrideK Kusano
Jun 14, 1974·Brain Research·A B YoungS H Snyder
May 21, 1971·Brain Research·S BistiP Strata
Oct 1, 1973·Jikken dobutsu. Experimental animals·S Oda
Dec 1, 1970·Brain Research·H Kawamura, L Provini
Jun 4, 1971·Brain Research·I A Hendry, L L Iversen
Aug 1, 1966·Journal of Neurochemistry·J Glowinski, L L Iversen
May 1, 1980·Journal of Neurochemistry·A C Foster, P J Roberts
Nov 1, 1976·Journal of Neurochemistry·I KanazawaJ S Kelly
Citations
Apr 1, 1985·Archives of Toxicology·K HirayamaT Fujisaki
Dec 12, 2012·Journal of Neural Transmission·Mitsuko HamamuraYasuyuki Fukumaki
Feb 19, 2009·The Cerebellum·Nam-Seob Lee, Young-Gil Jeong
May 23, 2009·The Cerebellum·Kenji Akita, Shigeyuki Arai
Aug 3, 1989·European Journal of Pharmacology·M Yamamoto, M Shimizu
Feb 14, 1995·European Journal of Pharmacology·K KinoshitaY Matsuoka
Sep 1, 1993·Journal of the Neurological Sciences·S EndoO Serizawa
Jan 1, 1982·Neurochemistry International·T YamaguchiI Sobue
May 21, 1999·Neuroscience Letters·I J RhyuL C Abbott
Jan 1, 1983·Folia Psychiatrica Et Neurologica Japonica·M NiimiY Aoki
May 1, 1992·British Journal of Pharmacology·N TokutomiN Akaike
Dec 1, 1995·British Journal of Pharmacology·K KinoshitaY Matsuoka
Mar 1, 1985·Epilepsia·T N Seyfried, G H Glaser
Jan 1, 1993·Epilepsia·S DolinaA Greenberg
Jul 22, 1999·Annals of the New York Academy of Sciences·D L Burgess, J L Noebels
Apr 19, 2002·Annals of the New York Academy of Sciences·John S Stahl
Dec 6, 2005·Biological & Pharmaceutical Bulletin·Tomoka NakamuraHideki Ono
Sep 7, 2012·PloS One·Weidong LiEiki Takahashi
Jun 2, 2009·The Cerebellum·Jaap J PlompSimon Kaja
Mar 3, 2009·Neuroscience·N FukumotoI Shibuya
Feb 24, 2012·Journal of Neurochemistry·Tim Aumann, Mal Horne
Dec 11, 1992·Brain Research·T YamaguchiK Akazawa
Apr 15, 1982·Brain Research·O MuramotoI Kanazawa
Apr 1, 1986·Acta Neurologica Scandinavica·Y ManoK Ando
Sep 1, 1983·Journal of Neurochemistry·H S SingerJ T Coyle